Cambridge, United Kingdom

Ben Grimshaw

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Ben Grimshaw

Introduction

Ben Grimshaw is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in T-cell therapies. With a total of 2 patents, Grimshaw's work is paving the way for advancements in medical treatments.

Latest Patents

Grimshaw's latest patents focus on protein-based T-cell receptor knockdown. This invention relates to the use of protein-based T-cell receptor knockdown in T-cell therapies, which has the potential to enhance the effectiveness of immunotherapies. His innovative approach aims to improve patient outcomes in various medical conditions.

Career Highlights

Grimshaw is currently associated with UCL Business Plc, where he continues to develop his groundbreaking ideas. His work has garnered attention in the scientific community, and he is recognized for his contributions to the advancement of T-cell therapies.

Collaborations

Grimshaw collaborates with Paul Maciocia, a fellow innovator in the field. Their partnership is focused on exploring new avenues in biotechnology and enhancing the efficacy of T-cell therapies.

Conclusion

Ben Grimshaw's contributions to the field of biotechnology, particularly through his patents on T-cell receptor knockdown, highlight his role as an influential inventor. His work continues to inspire advancements in medical therapies that could benefit many patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…